Psychedelic Business Spotlight: July 9, 2021
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
greenbrook
Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Cybin CEO says agreement “serves as a major step toward establishing a national distribution network for future psychedelic therapies.”
End of content
End of content